home / stock / tenx / tenx short
Short Information | Tenax Therapeutics Inc. (NASDAQ:TENX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 113,154 |
Total Actual Volume | 457,515 |
Short Trends | |
---|---|
Cover Days | 16 |
Short Days | 1 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 5,658 |
Average Short Percentage | 22.94% |
Is there a TENX Short Squeeze or Breakout about to happen?
See the TENX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $2.9633 | $3.17 | $3.2925 | $2.9633 | 54,984 | 19,757 | 35.93% |
07-01-2024 | $2.9723 | $3 | $3.0599 | $2.9501 | 16,485 | 3,201 | 19.42% |
06-28-2024 | $2.92 | $3.0148 | $3.12 | $2.92 | 4,161 | 494 | 11.87% |
06-27-2024 | $3.09 | $2.98 | $3.1495 | $2.95 | 24,130 | 3,564 | 14.77% |
06-26-2024 | $3.12 | $3.13 | $3.21 | $3.1 | 30,353 | 2,721 | 8.96% |
06-25-2024 | $3.0547 | $3.21 | $3.2319 | $3.05 | 23,962 | 9,697 | 40.47% |
06-24-2024 | $2.77 | $3.02 | $3.06 | $2.77 | 18,880 | 4,885 | 25.87% |
06-21-2024 | $3.09 | $2.77 | $3.09 | $2.77 | 51,254 | 8,125 | 15.85% |
06-20-2024 | $3.09 | $3.03 | $3.09 | $3.01 | 22,668 | 11,029 | 48.65% |
06-18-2024 | $3.1219 | $3.09 | $3.2 | $3.0617 | 17,748 | 2,230 | 12.56% |
06-17-2024 | $3.16 | $3.1 | $3.185 | $3.03 | 14,558 | 3,039 | 20.88% |
06-14-2024 | $3.24 | $3.14 | $3.32 | $3.08 | 19,447 | 1,143 | 5.88% |
06-13-2024 | $3.26 | $3.2 | $3.29 | $3.1593 | 17,228 | 3,732 | 21.66% |
06-12-2024 | $3.39 | $3.28 | $3.4795 | $3.23 | 56,272 | 15,918 | 28.29% |
06-11-2024 | $3.39 | $3.42 | $3.43 | $3.3624 | 16,120 | 2,981 | 18.49% |
06-10-2024 | $3.54 | $3.43 | $3.54 | $3.41 | 13,146 | 584 | 4.44% |
06-07-2024 | $3.535 | $3.45 | $3.54 | $3.45 | 10,535 | 795 | 7.55% |
06-06-2024 | $3.59 | $3.53 | $3.6 | $3.53 | 9,743 | 2,282 | 23.42% |
06-05-2024 | $3.51 | $3.58 | $3.6 | $3.4843 | 18,622 | 10,993 | 59.03% |
06-04-2024 | $3.55 | $3.47 | $3.58 | $3.4601 | 17,219 | 5,984 | 34.75% |
News, Short Squeeze, Breakout and More Instantly...
Tenax Therapeutics Inc. Company Name:
TENX Stock Symbol:
NASDAQ Market:
Tenax Therapeutics Inc. Website:
Currently Enrolling Patients in Phase 3 LEVEL Study with 24 Investigative Sites Initiated Secured Global Development and Commercial Rights to Levosimendan for Treatment of PH-HFpEF Expanded Intellectual Property Estate for Levosimendan with Issuance of New U.S. Patent ...
Broadens IP protection for oral (TNX-103), IV, and subcutaneous use of levosimendan, and its active metabolites (OR1896 and OR1855), in PH-HFpEF Provides U.S. intellectual property (IP) protection until December 2040, and may qualify for additional U.S. patent term extension (PTE) beyond ...